Enliven Therapeutics (ELVN) Amortizatization of Intangibles (2019 - 2026)
Enliven Therapeutics has reported Amortizatization of Intangibles over the past 8 years, most recently at -$266000.0 for Q1 2026.
- Quarterly results put Amortizatization of Intangibles at -$266000.0 for Q1 2026, down 691.11% from a year ago — trailing twelve months through Mar 2026 was -$84000.0 (up 91.92% YoY), and the annual figure for FY2025 was $227000.0, up 153.54%.
- Amortizatization of Intangibles reached -$266000.0 in Q1 2026 per ELVN's latest filing, down from -$55000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q3 2023 and bottomed at -$976000.0 in Q4 2024.
- Median Amortizatization of Intangibles over the past 5 years was $46500.0 (2022), compared with a mean of $295714.3.
- The largest annual shift saw Amortizatization of Intangibles surged 1631.25% in 2023 before it plummeted 691.11% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at $48000.0 in 2022, then soared by 3625.0% to $1.8 million in 2023, then tumbled by 154.59% to -$976000.0 in 2024, then surged by 94.36% to -$55000.0 in 2025, then crashed by 383.64% to -$266000.0 in 2026.
- Business Quant data shows Amortizatization of Intangibles for ELVN at -$266000.0 in Q1 2026, -$55000.0 in Q4 2025, and $310000.0 in Q3 2025.